Steris | STE - Frais De Vente Et D'Administration

Prix De L'Action
218.71
Variation Quotidienne
-1.23 -0.56%
Mensuellement
-10.13%
Annuel
-1.22%
Q2 Prévisions
212.13




Frais De Vente Et D'Administration Changement Date
3M USD 965M 145M 2025-12
Accuray USD 127.32M 500.16M 2025-09
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
CONMED USD 166.76M 26.42M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Ecolab USD 1.06B 18.2M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Fortive USD 417.4M 10.2M 2025-12
Getinge SEK 2.65B 452M 2024-12
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Hologic USD 2.5B 2.24B 2025-12
Idexx Laboratories USD 275.68M 10.58M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
J&J USD 6.75B 831M 2025-12
Masimo USD 128M 11.6M 2025-12
Olympus JPY 125.65B 5.75B 2025-12
Orthofix International USD 130.35M 11.31M 2025-12
Owens Minor USD 258.98M 7.5M 2025-12
ResMed USD 278.4M 19.2M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12